Changes in antidepressant metabolism and dosing across pregnancy and early postpartum
about
Postpartum psychiatric disorders: Early diagnosis and managementPlacental transfer of antidepressant medications: implications for postnatal adaptation syndromePharmacotherapy of postpartum depression: an updatePharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoringPregnancy-Associated Changes in Pharmacokinetics: A Systematic ReviewAntidepressant use in pregnancy: a critical review focused on risks and controversiesPrenatal antidepressant exposure: clinical and preclinical findings.Stress sensitive female macaques have decreased fifth Ewing variant (Fev) and serotonin-related gene expression that is not reversed by citalopram.Ethical issues in perinatal mental health researchPharmacogenetics and individualizing drug treatment during pregnancy.Returning to tricyclic antidepressants for depression during childbearing: clinical and dosing challenges.Forced swim test behavior in postpartum ratsEarly pregnancy exposure to selective serotonin reuptake inhibitors, risks of major structural malformations, and hypothesized teratogenic mechanisms.Interactions of corticotropin-releasing factor, urocortin and citalopram in a primate model of stress-induced amenorrhea.Lactating mother and psychotropic drugs.Treatment of postpartum depression: clinical, psychological and pharmacological optionsBiologically based treatment approaches to the patient with resistant perinatal depression.Disposition of chiral and racemic fluoxetine and norfluoxetine across childbearing.Mother-infant antidepressant concentrations, maternal depression, and perinatal eventsEffect of pregnancy on the disposition of 2,2',3,5',6-pentachlorobiphenyl (PCB 95) atropisomers and their hydroxylated metabolites in female miceCOLLABORATIVE CARE FOR PERINATAL DEPRESSION IN SOCIOECONOMICALLY DISADVANTAGED WOMEN: A RANDOMIZED TRIAL.Prescribing without evidence - pregnancy.A pregnancy physiologically based pharmacokinetic (p-PBPK) model for disposition of drugs metabolized by CYP1A2, CYP2D6 and CYP3A4Pharmacotherapy and pregnancy: highlights from the Second International Conference for Individualized Pharmacotherapy in Pregnancy.Anhedonia in postpartum ratsAltered expression of small heterodimer partner governs cytochrome P450 (CYP) 2D6 induction during pregnancy in CYP2D6-humanized mice.Factors affecting the development of adverse drug reactions (Review article)Adherence of antidepressants during pregnancy: MEMS compared with three other methods.Family history, not lack of medication use, is associated with the development of postpartum depression in a high-risk sample.Unipolar depression during pregnancy: nonpharmacologic treatment options.Maternal use of antidepressant or anxiolytic medication during pregnancy and childhood neurodevelopmental outcomes: a systematic review.Risk-benefit balance assessment of SSRI antidepressant use during pregnancy and lactation based on best available evidence.A pharmacological approach to panic disorder during pregnancy.Use of psychotropic drugs during pregnancy and breast-feeding.Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition.Treatment with antipsychotics in pregnancy: Changes in drug disposition.5-HT2B receptors are expressed on astrocytes from brain and in culture and are a chronic target for all five conventional 'serotonin-specific reuptake inhibitors'.Quetiapine Dose Adjustments in Pregnant and Postpartum Women With Bipolar Disorder.Increased incidence of non-alcoholic fatty liver disease in male rat offspring exposed to fluoxetine during fetal and neonatal life involves the NLRP3 inflammasome and augmented de novo hepatic lipogenesis.Pregnancy and pharmacogenomics in the context of drug metabolism and response.
P2860
Q26795414-5C3F44C6-5077-4E15-951C-04A79FA854E0Q26999391-167EA727-83F9-4CBF-B151-E88106BB74B2Q27010062-9DA0DF7B-7845-4B59-BBD3-75F329839187Q27027293-FAA13263-E9A1-440D-9867-14BDD3BAB72BQ28109657-C002704C-213F-430B-BA10-85F88961E85FQ28281407-6275E610-B569-45AC-9BDD-73345D8184A5Q30415540-BE5B6919-A52B-4CDE-B9EE-F2D19B5BD2A1Q30490951-360D1D40-2A7F-47F7-AC05-31716E767962Q33738831-F7AB1182-1046-4EEC-9F07-9F5FADA0E373Q33781272-F534647C-6DF6-42AF-B767-1E1A13EC86CDQ33976001-2C75DF8C-853C-430F-BB5A-166B5CEB066BQ34151369-311A2859-20E7-49E7-B8A0-7C63F5F7DA94Q34483257-F2DD5D6D-ACBB-4018-8FD5-7F04229E7F0DQ34515559-CE892FEF-F258-42B8-88B6-085295BEB442Q34543929-11659C4E-E3AD-4068-BC72-D0E8251897C8Q34574118-55D9FB42-646C-46C7-9E41-9A6C01E29C4BQ34799159-224DC470-7E87-4AB7-A882-9894B9D9279EQ35030007-EB5A2D31-0A6D-4598-9CC7-04D28F0E7EFEQ35172179-6CF67249-1705-414E-B290-5B4B8FCD8B36Q36083543-B2B20183-253B-4E64-AAF5-0150B6D50692Q36240467-4D5D0593-8920-4AF1-B836-FB91DED6667DQ36336002-F3E34F95-DBCE-41C0-A499-8D16955F5905Q36390289-9C871B42-04A6-4E31-A871-A6EAE243324DQ36810933-5CAB33E1-0703-4271-A853-ABE611529EE5Q37480756-F9C00445-7932-49F9-8F92-C8E4855AB8DEQ37563369-38CF2AD7-B2DF-4C98-B553-A94775A680C0Q37631543-3395FB1E-F928-4415-A995-4153CB2FD918Q37634873-88AC776F-A624-46C0-8E8C-75B4297FEB42Q37666024-9031CE78-59B9-4FA8-AEC7-4137BAC1C771Q37769525-3289AAAD-1D4A-4208-94F7-360706987A8EQ38215072-8902FB91-24C9-4351-821C-4FF9AB30BCB7Q38305749-4FCCF1EB-C99B-4B04-90BB-0B3294837565Q38516009-9021660C-6438-4E8C-B2E9-2A50ADDA7750Q38582061-F1A3B887-669D-41BD-BF84-F9FA2BE7D874Q38678838-FB82790E-EF13-4F70-968D-61BF8413961FQ38712679-6E424EF5-CE30-40EF-B5CA-38020DA27164Q42905649-A8670D78-6F35-4BDF-B4BC-AD6567829E58Q47690894-574E9D6E-8438-43D3-9C66-64B68FE85D76Q47709525-DC68C4D7-415B-48C0-8C07-19733E3BC278Q54659609-033B5D92-790E-43B0-AA0D-C05F49447D42
P2860
Changes in antidepressant metabolism and dosing across pregnancy and early postpartum
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Changes in antidepressant metabolism and dosing across pregnancy and early postpartum
@ast
Changes in antidepressant metabolism and dosing across pregnancy and early postpartum
@en
type
label
Changes in antidepressant metabolism and dosing across pregnancy and early postpartum
@ast
Changes in antidepressant metabolism and dosing across pregnancy and early postpartum
@en
prefLabel
Changes in antidepressant metabolism and dosing across pregnancy and early postpartum
@ast
Changes in antidepressant metabolism and dosing across pregnancy and early postpartum
@en
P2093
P2860
P356
P1476
Changes in antidepressant metabolism and dosing across pregnancy and early postpartum
@en
P2093
Dorothy K Sit
James M Perel
Joseph C Helsel
Katherine L Wisner
P2860
P304
P356
10.4088/JCP.V69N0419
P577
2008-04-01T00:00:00Z